Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783623502> ?p ?o ?g. }
- W2783623502 endingPage "34" @default.
- W2783623502 startingPage "34" @default.
- W2783623502 abstract "Azemiopsin (Az), a linear peptide from the Azemiops feae viper venom, contains no disulfide bonds, is a high-affinity and selective inhibitor of nicotinic acetylcholine receptor (nAChR) of muscle type and may be considered as potentially applicable nondepolarizing muscle relaxant. In this study, we investigated its preclinical profile in regard to in vitro and in vivo efficacy, acute and chronic toxicity, pharmacokinetics, allergenic capacity, immunotoxicity and mutagenic potency. The peptide effectively inhibited (IC50 ~ 19 nM) calcium response of muscle nAChR evoked by 30 μM (EC100) acetylcholine but was less potent (IC50 ~ 3 μM) at α7 nAChR activated by 10 μM (EC50) acetylcholine and had a low affinity to α4β2 and α3-containing nAChR, as well as to GABAA or 5HT₃ receptors. Its muscle relaxant effect was demonstrated at intramuscular injection to mice at doses of 30-300 µg/kg, 30 µg/kg being the initial effective dose and 90 µg/kg-the average effective dose. The maximal muscle relaxant effect of Az was achieved in 10 min after the administration and elimination half-life of Az in mice was calculated as 20-40 min. The longest period of Az action observed at a dose of 300 µg/kg was 55 min. The highest acute toxicity (LD50 510 μg/kg) was observed at intravenous injection of Az, at intramuscular or intraperitoneal administration it was less toxic. The peptide showed practically no immunotoxic, allergenic or mutagenic capacity. Overall, the results demonstrate that Az has good drug-like properties for the application as local muscle relaxant and in its parameters, is not inferior to the relaxants currently used. However, some Az modification might be effective to extend its narrow therapeutic window, a typical characteristic and a weak point of all nondepolarizing myorelaxants." @default.
- W2783623502 created "2018-01-26" @default.
- W2783623502 creator A5013445678 @default.
- W2783623502 creator A5019653809 @default.
- W2783623502 creator A5020896135 @default.
- W2783623502 creator A5028468391 @default.
- W2783623502 creator A5029195906 @default.
- W2783623502 creator A5037875471 @default.
- W2783623502 creator A5049796515 @default.
- W2783623502 creator A5057031839 @default.
- W2783623502 creator A5064741856 @default.
- W2783623502 creator A5068568479 @default.
- W2783623502 creator A5069934010 @default.
- W2783623502 creator A5071203667 @default.
- W2783623502 creator A5071643441 @default.
- W2783623502 creator A5083142298 @default.
- W2783623502 creator A5084472524 @default.
- W2783623502 date "2018-01-07" @default.
- W2783623502 modified "2023-10-01" @default.
- W2783623502 title "Azemiopsin, a Selective Peptide Antagonist of Muscle Nicotinic Acetylcholine Receptor: Preclinical Evaluation as a Local Muscle Relaxant" @default.
- W2783623502 cites W1444776473 @default.
- W2783623502 cites W1485755392 @default.
- W2783623502 cites W1490309086 @default.
- W2783623502 cites W181418607 @default.
- W2783623502 cites W1964925177 @default.
- W2783623502 cites W1967637447 @default.
- W2783623502 cites W1968773624 @default.
- W2783623502 cites W1984498541 @default.
- W2783623502 cites W1988425788 @default.
- W2783623502 cites W1993734304 @default.
- W2783623502 cites W1993945066 @default.
- W2783623502 cites W1994510026 @default.
- W2783623502 cites W1997901145 @default.
- W2783623502 cites W2001748700 @default.
- W2783623502 cites W2006241929 @default.
- W2783623502 cites W2011317359 @default.
- W2783623502 cites W2013613444 @default.
- W2783623502 cites W2026553683 @default.
- W2783623502 cites W2061266283 @default.
- W2783623502 cites W2061593902 @default.
- W2783623502 cites W2072243851 @default.
- W2783623502 cites W2092325050 @default.
- W2783623502 cites W2092345136 @default.
- W2783623502 cites W2107614487 @default.
- W2783623502 cites W2114813632 @default.
- W2783623502 cites W2130814618 @default.
- W2783623502 cites W2131134103 @default.
- W2783623502 cites W2149441166 @default.
- W2783623502 cites W2159675295 @default.
- W2783623502 cites W2327654344 @default.
- W2783623502 cites W2741961446 @default.
- W2783623502 cites W2745233758 @default.
- W2783623502 cites W2766490833 @default.
- W2783623502 cites W3084182395 @default.
- W2783623502 cites W4240346568 @default.
- W2783623502 doi "https://doi.org/10.3390/toxins10010034" @default.
- W2783623502 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5793121" @default.
- W2783623502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29316656" @default.
- W2783623502 hasPublicationYear "2018" @default.
- W2783623502 type Work @default.
- W2783623502 sameAs 2783623502 @default.
- W2783623502 citedByCount "23" @default.
- W2783623502 countsByYear W27836235022018 @default.
- W2783623502 countsByYear W27836235022019 @default.
- W2783623502 countsByYear W27836235022020 @default.
- W2783623502 countsByYear W27836235022021 @default.
- W2783623502 countsByYear W27836235022022 @default.
- W2783623502 countsByYear W27836235022023 @default.
- W2783623502 crossrefType "journal-article" @default.
- W2783623502 hasAuthorship W2783623502A5013445678 @default.
- W2783623502 hasAuthorship W2783623502A5019653809 @default.
- W2783623502 hasAuthorship W2783623502A5020896135 @default.
- W2783623502 hasAuthorship W2783623502A5028468391 @default.
- W2783623502 hasAuthorship W2783623502A5029195906 @default.
- W2783623502 hasAuthorship W2783623502A5037875471 @default.
- W2783623502 hasAuthorship W2783623502A5049796515 @default.
- W2783623502 hasAuthorship W2783623502A5057031839 @default.
- W2783623502 hasAuthorship W2783623502A5064741856 @default.
- W2783623502 hasAuthorship W2783623502A5068568479 @default.
- W2783623502 hasAuthorship W2783623502A5069934010 @default.
- W2783623502 hasAuthorship W2783623502A5071203667 @default.
- W2783623502 hasAuthorship W2783623502A5071643441 @default.
- W2783623502 hasAuthorship W2783623502A5083142298 @default.
- W2783623502 hasAuthorship W2783623502A5084472524 @default.
- W2783623502 hasBestOaLocation W27836235021 @default.
- W2783623502 hasConcept C170493617 @default.
- W2783623502 hasConcept C185592680 @default.
- W2783623502 hasConcept C188987157 @default.
- W2783623502 hasConcept C2775910092 @default.
- W2783623502 hasConcept C2776860028 @default.
- W2783623502 hasConcept C2779570518 @default.
- W2783623502 hasConcept C2909754679 @default.
- W2783623502 hasConcept C55493867 @default.
- W2783623502 hasConcept C71924100 @default.
- W2783623502 hasConcept C80161118 @default.
- W2783623502 hasConcept C98274493 @default.
- W2783623502 hasConceptScore W2783623502C170493617 @default.
- W2783623502 hasConceptScore W2783623502C185592680 @default.